The objective of this paper was to evaluate correlations between kidney biopsy indexes (activity and chronicity) and urinary sediment findings; the secondary objective was to find which components of urinary sediment can discriminate proliferative from other classes of lupus nephritis.
Methods
Lupus nephritis patients scheduled for a kidney biopsy were included in our study. The morning before the kidney biopsy, we took urine samples from each patient. Receiver operating characteristic (ROC) curves were plotted to determine the area under the curve (AUC) of each test for detecting proliferative lupus nephritis; a classification tree was calculated to select a set of values that best-predicted lupus nephritis classes.
Results
We included 51 patients, 36 of whom were women (70.6%). Correlations of lupus nephritis activity index with the counts in the urinary sediment of erythrocytes (isomorphic and dysmorphic), acanthocytes, and leukocytes were 0.65 (p < 0.0001) 0.62 (p < 0.0001) and 0.22 (p = 0.1228), respectively. Correlations of lupus nephritis chronicity index with the counts of erythrocytes, acanthocytes, and leukocytes were 0.60 (p ≤ 0.0001), 0.52 (p = 0.0001) and 0.17 (p = 0.2300), respectively. Our classification tree had an accuracy of 84.3%.
Conclusions
Evaluation of urine sediment reflects lupus nephritis histology.
MohanCPuttermanC. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol2015; 11: 329–341.
2.
MokCCKwokRCYipPS. Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus. Arthritis Rheum2013; 65: 2154–2160.
3.
ChanTM. Treatment of severe lupus nephritis: The new horizon. Nat Rev Nephrol2015; 11: 46–61.
4.
ParikhSVAlvaradoAMalvarARovinBH. The kidney biopsy in lupus nephritis: Past, present, and future. Semin Nephrol2015; 35: 465–477.
5.
AustinHA3rdMuenzLRJoyceKMAntonovychTTBalowJE. Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome. Kidney Int1984; 25: 689–695.
6.
AustinHA3rdMuenzLRJoyceKM. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med1983; 75: 382–391.
7.
AlsuwaidaAHusainSAlghonaimM. Strategy for second kidney biopsy in patients with lupus nephritis. Nephrol Dial Transplant2012; 27: 1472–1478.
MakinoHNishimuraSSodaKTakaokaMKaneshigeTOtaZ. Mechanism of hematuria. I. Electron microscopic demonstration of the passage of a red blood cell through a glomerular capillary wall in rat masugi nephritis. Virchows Arch B Cell Pathol Incl Mol Pathol1986; 50: 199–208.
11.
PetriMOrbaiAMAlarcónGS. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum2012; 64: 2677–2686.
12.
MohammadKSBdeshaASSnellMEWitherowROColemanDV. Phase contrast microscopic examination of urinary erythrocytes to localise source of bleeding: An overlooked technique?J Clin Pathol1993; 46: 642–645.
13.
WeeningJJD’AgatiVDSchwartzMM. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol2004; 15: 241–250.
14.
PencinaMJD’AgostinoRBSrD’AgostinoRBJrVasanRS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med2008; 27: 157–172; discussion 207–212.
15.
AustinHA3rdBoumpasDTVaughanEMBalowJE. Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data. Kidney Int1994; 45: 544–550.
16.
EsdaileJMAbrahamowiczMMacKenzieTHayslettJPKashgarianM. The time-dependence of long-term prediction in lupus nephritis. Arthritis Rheum1994; 37: 359–368.
BessisM. Red cell shapes An illustrated classification and its rationale. Nouv Rev Fr Hematol1972; 12: 721–745.
19.
XuejingZJiazhenTJunLXianggingXShuguangYFuyouL. Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases. J Biomed Biotechnol2012; 2012: 359647–359647.
20.
ConsolaroAVarnierGCMartiniARavelliA. Advances in biomarkers for paediatric rheumatic diseases. Nat Rev Rheumatol2015; 11: 265–275.
21.
MisraRGuptaR. Biomarkers in lupus nephritis. Int J Rheum Dis2015; 18: 219–232.
22.
Malvar A, Pirruccio P, Alberton V, et al. Histologic versus clinical remission in proliferative lupus nephritis. Nephrol Dial Transplant. Epub ahead of print 6 August 2015. DOI: 10.1093/ndt/gfv296.
23.
ZickertASundelinBSvenungssonEGunnarssonI. Role of early repeated renal biopsies in lupus nephritis. Lupus Sci Med2014; 1: e000018–e000018.
24.
De RosaMAToblliJEDe RosaGE. Could proteinuria less than 500 mg/day be an actual indicator of lupus nephritis biopsy. J Am Soc Nephrol2013. Annual meeting abstracts: PO720.
25.
EnghardPRiederCKopetschkeK. Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response. Ann Rheum Dis2014; 73: 277–283.
26.
MavraganiCPFragoulisGESomarakisGDrososATzioufasAGMoutsopoulosHM. Clinical and laboratory predictors of distinct histopathogical [sic] features of lupus nephritis. Medicine (Baltimore)2015; 94: e829–e829.
27.
Dall’EraMCisternasMGSmilekDE. Predictors of long-term renal outcome in lupus nephritis trials: Lessons learned from the Euro-Lupus Nephritis Cohort. Arthritis Rheumatol2015; 67: 1305–1313.
28.
Ben-YehudaARasoolyLBar-TanaR. The urine of SLE patients contains antibodies that bind to the laminin component of the extracellular matrix. J Autoimmun1995; 8: 279–291.
29.
BiçerIAksuKParildarZTanyalçinTDoğanavşargilEKutayFZ. Increased excretions of glycosaminoglycans and heparan sulfate in lupus nephritis and rheumatoid arthritis. Rheumatol Int2003; 23: 221–225.
30.
ChanRWLaiFMLiEK. Urinary mononuclear cell and disease activity of systemic lupus erythematosus. Lupus2006; 15: 262–267.
31.
HammadAMosaadYElhanblyS. Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children. Lupus2013; 22: 486–491.
32.
MarksSDShahVPilkingtonCTullusK. Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis. Pediatr Nephrol2010; 25: 2283–2288.
33.
MirandaJMPrietoREPaniaguaR. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. Lupus1998; 7: 387–391.
34.
SchwartzNRubinsteinTBurklyLC. Urinary TWEAK as a biomarker of lupus nephritis: A multicenter cohort study. Arthritis Res Ther2009; 11: R143–R143.
35.
SuzukiMWiersKMKlein-GitelmanMS. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol2008; 23: 403–412.
36.
SuzukiMRossGFWiersK. Identification of a urinary proteomic signature for lupus nephritis in children. Pediatr Nephrol2007; 22: 2047–2057.
37.
WatsonLMidgleyAPilkingtonC. Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus. Lupus2012; 21: 496–501.
38.
ChanRWLaiFMLiEK. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis. Nephrol Dial Transplant2006; 21: 1534–1540.
